newsfilter
← Latest News
GlobeNewswire·

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada

SAN DIEGO and CLERMONT-FERRAND, France, July 07, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (NASDAQ:LENZ) and Laboratoires Théa ("Théa") announced an exclusive license and commercialization agreement for Théa to